doi: 10.1053/j.gastro.2007.03.054 24 YangFZengFLuoXLeiYLiJLuSet al
PMID: 40437949
Ozempic, Wegovy, Mounjaro, Zepbound - once positioned as diabetes and obesity innovations - are now being discussed in addiction clinics, neuroscientist labs, and policy circles for something far more consequential: the possibility that these drugs may blunt cravings for alcohol, nicotine, opioids, and other substances
Who is likely to see the biggest change in fat distribution
KIm | My liver feels a lot better, and my blood tests improved
Patients should be aware that some products sold as semaglutide may not contain the same active ingredient as FDA-approved semaglutide products and may be salt formulations, the FDA wrote